Učitavanje...
Anti-HIV-1 Therapeutics: From FDA-approved Drugs to Hypothetical Future Targets
More than twenty-five years after its discovery, HIV-1 remains one of the world’s most formidable and destructive pathogens. Several classes of anti-HIV-1 agents are currently in widespread clinical use in developed nations; however, viral resistance to these drugs limits their effectiveness in a gr...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Pharmacology and Experimental Therapeutics
2009
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2861802/ https://ncbi.nlm.nih.gov/pubmed/19401538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mi.9.2.5 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|